Characteristic dysbiosis in patients with type 2 diabetes and hyperuricemia, and the effect of empagliflozin on gut microbiota
Gut dysbiosis may contribute to the pathogenesis of HUA in T2DM, and empagliflozin may partly restore the gut microbiota related to uric acid metabolism.
Authors
- Lingyun Zhao (ORCID: https://orcid.org/0000-0001-8799-7496)
- Xinru Deng (ORCID: https://orcid.org/0000-0003-3747-9310)
- Huijuan Yuan (ORCID: https://orcid.org/0000-0002-0486-0994)
- Shasha Tang
- Yuanyuan Fang (ORCID: https://orcid.org/0000-0002-1313-1259)
- Yujia Zhai (ORCID: https://orcid.org/0000-0001-5276-4406)
- Xiaoyang Shi
- Hong Lee Heng
Institutions
- Henan Provincial People's Hospital (CN)
Publication Details
- Journal
- World Journal of Diabetes
- Published
- 2025-02-28
- DOI
- https://doi.org/10.4239/wjd.v16.i4.102970
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00